Coenzyme Q10 before IVF for low ovarian response
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests whether taking coenzyme Q10 before in vitro fertilization (IVF) can improve egg quality and increase the chances of a successful pregnancy for women with a low ovarian response. It may help if you have had few eggs retrieved in past IVF cycles or have low ovarian reserve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have IVF treatment to get pregnant.
- You have been diagnosed with poor ovarian response, such as having had 3 or fewer eggs retrieved in a previous IVF cycle, or having low ovarian reserve (low antral follicle count or AMH level).
- You are under 40 years old.
- Your body mass index (BMI) is between 18.5 and 28.0.
- You have not had more than 3 previous IVF stimulation cycles.
- You are willing to take the study supplement and avoid certain medications and supplements for 3 months before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two forms of coenzyme Q10 (ubiquinone vs. ubiquinol) to see if either improves egg quality or IVF success. It may be a good fit if you are between 37 and 43, doing your first IVF cycle, and have certain hormone levels within a normal range.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
This trial tests whether taking testosterone before IVF can improve egg quality and pregnancy chances in women with low ovarian reserve. It is specifically for women with a certain genetic marker in the androgen receptor.
This trial tests whether taking alpha-lipoic acid (an antioxidant supplement) before and during IVF can improve pregnancy success in women aged 35–45 using their own eggs. It aims to see if the supplement can help counter age-related declines in egg quality.
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
Hear when a new Ovarian Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.